RICHTVXNEWS
GSK shares dive as weaker sales and mounting costs unnerve investors
THE GUARDIAN · LONDON — British pharma company reports declining profits amid weaker vaccine sales and looming patent loss for blockbuster HIV drug Business live – latest updates Shares in GSK slid on Wednesday despite the UK drugmaker reporting better-than-expected financial results, as investors were unnerved by weaker vaccine sales…
- CODE
- RT-890A03
- PUBLISHER
- The Guardian
- TOPIC
- World
- PUBLISHED
- 28 October 2026 · 12:44 UTC
- FIRST SEEN
- 28 October 2026 · 13:00 UTC
- ORIGINAL
- https://www.theguardian.com/business/2026/oct/28/gsk-shares-dive-as-weaker-sales-and-mounting-costs-unnerve-investors
- SHA-256
- adeeab6891d71396f930a97d3464872e122904fb61b40f9a2f5c1f2db74f63fa
The fingerprint is the SHA-256 of the original link, the headline and the publication time joined by “|”. Anyone can recompute it to confirm the headline and link were not changed here.
Headline and short excerpt from The Guardian, taken from its public news feed. The full story and its photos belong to The Guardian — read it at the original. RICHTVX NEWS is an independent aggregator and is not affiliated with The Guardian. Corrections: legal@richtvx.news.